MA49520A - Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation - Google Patents

Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation

Info

Publication number: MA49520A
Authority: MA; Morocco
Prior art keywords: silk; methods; hyaluronic acid; tissue fillers; acid tissue
Prior art date: 2017-06-26

Application number

MA049520A

Other languages

English (en)

Inventor

Gregory H Altman

Erlei Jin

Peng Xu

Original Assignee

Evolved By Nature Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-06-26

Filing date

2018-06-26

Publication date

2021-04-14

2018-06-26 Application filed by Evolved By Nature Inc filed Critical Evolved By Nature Inc

2021-04-14 Publication of MA49520A publication Critical patent/MA49520A/fr

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
- A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/26—Mixtures of macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Oral & Maxillofacial Surgery (AREA)
Transplantation (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Materials For Medical Uses (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

MA049520A 2017-06-26 2018-06-26 Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation MA49520A (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US201762525131P	2017-06-26	2017-06-26
US201862641095P	2018-03-09	2018-03-09

Publications (1)

Publication Number	Publication Date
MA49520A true MA49520A (fr)	2021-04-14

Family

ID=64742709

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA049520A MA49520A (fr)	2017-06-26	2018-06-26	Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation

Country Status (14)

Country	Link
US (1)	US20230338614A1 (fr)
EP (2)	EP4169539B1 (fr)
JP (3)	JP2020525253A (fr)
KR (1)	KR20200032103A (fr)
CN (1)	CN111263646A (fr)
AU (2)	AU2018290810C1 (fr)
CA (1)	CA3068296A1 (fr)
CO (1)	CO2020000774A2 (fr)
ES (2)	ES3018883T3 (fr)
IL (2)	IL299584A (fr)
MA (1)	MA49520A (fr)
SG (1)	SG11201913229PA (fr)
UA (1)	UA127350C2 (fr)
WO (1)	WO2019005848A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20230190997A1 (en)	2017-06-26	2023-06-22	Evolved By Nature, Inc.	Silk-hyaluronic acid based tissue filers and methods of using the same
CN113584593B (zh)	2017-09-21	2024-01-02	住友电气工业株式会社	半绝缘性砷化镓晶体基板
US12296067B2 (en)	2018-12-19	2025-05-13	Evolved By Nature, Inc.	Silk-hyaluronic acid tissue fillers and methods of making and using the same
US20220193305A1 (en) *	2019-03-29	2022-06-23	Trustees Of Tufts College	Crosslinked silk fibroin-based compositions, and methods of making and using the same
US20220313590A1 (en) *	2019-06-06	2022-10-06	Evolved By Nature, Inc.	Silk stimulated collagen production and methods of use thereof
US20220355626A1 (en) *	2019-06-26	2022-11-10	Compagnie Generale Des Etablissements Michelin	A noise improving tread
CN110339398A (zh) *	2019-07-18	2019-10-18	王月玲	一种含氨基酸透明质酸钠注射剂及其制备方法
EP4017537A4 (fr) *	2019-08-20	2023-08-16	Evolved by Nature, Inc.	Compositions de soins personnels à base de soie
CN114206996B (zh) *	2019-09-27	2024-01-02	株式会社Lg化学	制备聚合物微粒的方法，聚合物微粒，使用其的医用组合物、美容组合物、医用制品和美容制品
ES2985960T3 (es) *	2019-12-19	2024-11-07	Croma Pharma Gmbh	Hialuronano modificado con tiol e hidrogel que comprende el hialuronano reticulado
CN116507315A (zh) *	2020-06-19	2023-07-28	自然进化公司	用于组织填充、组织间隔和组织膨胀的丝-透明质酸组合物
CA3183134A1 (fr) *	2020-06-19	2021-12-23	Gregory H. Altman	Compositions de soie-acide hyaluronique pour le remplissage tissulaire, l'espacement tissulaire et le gonflement tissulaire
JP2024519426A (ja) *	2020-09-29	2024-05-14	ジロパ・インコーポレイテッド	疼痛の緩和及び麻痺のための組成物及び方法
TR202101065A1 (tr) *	2021-01-25	2022-08-22	Hacettepe Ueniversitesi	Hyaluroni̇k asi̇t jel i̇çeren bi̇r doku dolgu malzemesi̇ ve üreti̇m yöntemi̇
CN118909068A (zh) *	2021-02-08	2024-11-08	复向丝泰医疗科技(苏州)有限公司	利用切向流超滤技术制备可控高浓度丝素蛋白溶液的方法
JP7695344B2 (ja)	2021-05-21	2025-06-18	ケンブリッジクロップスインコーポレイテッド．ドゥーイングビジネスアズモリ	絹フィブロイン溶液及び絹フィブロインを含む粉末を製造するためのシステム及び方法
WO2023275278A1 (fr) *	2021-06-30	2023-01-05	Merz Pharma Gmbh & Co. Kgaa	Charges dermiques d'acide hyaluronique réticulées avec de l'éther diglycidique de glycol polyéthylénique, leur procédé de fabrication et leurs utilisations
CN113368220A (zh) *	2021-07-05	2021-09-10	云南维他源生物科技有限公司	一种ahco组合物及其制剂与应用
KR20230013682A (ko)	2021-07-16	2023-01-27	주식회사 휴메딕스	Pegde로 가교된 히알루론산 필러 및 이의 제조방법
US11864569B2 (en)	2021-08-16	2024-01-09	Cambridge Crops, Inc.	Systems and methods for improving the performance of cereal using a silk fibroin solution and powders containing silk fibroin
CN114028610B (zh) *	2021-10-26	2022-10-25	北京诺康达医药科技股份有限公司	一种亲水性注射型皮肤填充组合物及其制备方法与应用
KR102766244B1 (ko) *	2024-02-16	2025-02-10	충남대학교 산학협력단	Lc-ms/ms 기반의 히알루론산, bdde 및 bdde 가교된 히알루론산의 정량방법

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH564031A5 (fr)	1968-03-29	1975-07-15	Anvar
FR2334107A1 (fr)	1975-12-05	1977-07-01	Pasteur Institut	Procede de couplage de substances biologiques par des liaisons covalentes
US4355023A (en)	1980-09-30	1982-10-19	The Massachusetts General Hospital	Antibody fragment compositions and process
US4657853A (en)	1984-09-14	1987-04-14	E. I. Du Pont De Nemours And Company	Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody
US4676980A (en)	1985-09-23	1987-06-30	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Target specific cross-linked heteroantibodies
US20060105022A1 (en)	2004-11-15	2006-05-18	Shiseido Co., Ltd.	Process for preparing crosslinked hyaluronic acid gel
US8357795B2 (en) *	2008-08-04	2013-01-22	Allergan, Inc.	Hyaluronic acid-based gels including lidocaine
US20110189292A1 (en)	2009-04-20	2011-08-04	Allergan, Inc.	Dermal fillers comprising silk fibroin hydrogels and uses thereof
US20120301441A1 (en) *	2009-11-11	2012-11-29	Hermanus Bernardus Johannes Karperien	Dextran-hyaluronic acid based hydrogels
US9149422B2 (en) *	2011-06-03	2015-10-06	Allergan, Inc.	Dermal filler compositions including antioxidants
KR20200116168A (ko) *	2011-09-14	2020-10-08	알러간, 인코포레이티드	잔주름 치료를 위한 진피 필러 조성물
CN102836465B (zh) *	2012-08-30	2014-06-04	浙江星月生物科技股份有限公司	一种注射用丝素蛋白透明质酸复合凝胶及其制备与应用
WO2014055895A1 (fr) *	2012-10-05	2014-04-10	Allergan, Inc.	Dispositif injectable et méthode de modelage, d'augmentation ou de correction de traits faciaux tels que du menton
US20140315828A1 (en) *	2013-04-22	2014-10-23	Allergan, Inc.	Cross-linked silk-hyaluronic acid compositions
US10077320B2 (en)	2013-06-28	2018-09-18	Galderma S.A.	Process for preparing a cross-linked hyaluronic acid product
SG10201907426UA (en) *	2013-09-30	2019-09-27	Evolved By Nature Inc	Silk protein fragment compositions and articles manufactured therefrom
PE20171791A1 (es)	2014-12-02	2017-12-28	Silk Therapeutics Inc	Prendas de vestir de seda y productos de alto rendimiento y metodos para elaborarla
DK3288528T3 (da) *	2015-04-29	2021-04-06	Evolved By Nature Inc	Silkebaserede fugtighedscremesammensætninger og fremgangsmåder deraf
US10175996B2 (en)	2016-05-02	2019-01-08	Norman R. Byrne	Information display and control for work areas
EP3503841A4 (fr) *	2016-08-24	2020-04-22	Allergan, Inc.	Hydrogels co-réticulés d'acide hyaluronique-fibroïne pour améliorer la viabilité des greffes tissulaires et pour l'augmentation des tissus mous

2018
- 2018-06-26 EP EP22197284.7A patent/EP4169539B1/fr active Active
- 2018-06-26 EP EP18823073.4A patent/EP3645063B1/fr active Active
- 2018-06-26 ES ES22197284T patent/ES3018883T3/es active Active
- 2018-06-26 JP JP2020520437A patent/JP2020525253A/ja active Pending
- 2018-06-26 IL IL299584A patent/IL299584A/en unknown
- 2018-06-26 CA CA3068296A patent/CA3068296A1/fr active Pending
- 2018-06-26 MA MA049520A patent/MA49520A/fr unknown
- 2018-06-26 WO PCT/US2018/039574 patent/WO2019005848A1/fr not_active Ceased
- 2018-06-26 KR KR1020207002371A patent/KR20200032103A/ko not_active Ceased
- 2018-06-26 AU AU2018290810A patent/AU2018290810C1/en active Active
- 2018-06-26 CN CN201880055268.1A patent/CN111263646A/zh active Pending
- 2018-06-26 UA UAA202000401A patent/UA127350C2/uk unknown
- 2018-06-26 ES ES18823073T patent/ES2935887T3/es active Active
- 2018-06-26 SG SG11201913229PA patent/SG11201913229PA/en unknown
2019
- 2019-12-24 IL IL271692A patent/IL271692B2/en unknown
2020
- 2020-01-23 CO CONC2020/0000774A patent/CO2020000774A2/es unknown
2023
- 2023-04-25 US US18/306,965 patent/US20230338614A1/en active Pending
- 2023-07-28 JP JP2023122912A patent/JP7660619B2/ja active Active
2024
- 2024-09-10 AU AU2024219582A patent/AU2024219582A1/en active Pending
- 2024-11-01 JP JP2024192754A patent/JP2025020289A/ja active Pending

Also Published As

Publication number	Publication date
BR112019027687A2 (pt)	2020-09-15
AU2018290810B2 (en)	2024-06-13
JP2023139249A (ja)	2023-10-03
JP7660619B2 (ja)	2025-04-11
SG11201913229PA (en)	2020-01-30
JP2020525253A (ja)	2020-08-27
CA3068296A1 (fr)	2019-01-03
AU2018290810C1 (en)	2024-09-12
IL299584A (en)	2023-03-01
CO2020000774A2 (es)	2020-05-05
AU2018290810A1 (en)	2020-02-13
KR20200032103A (ko)	2020-03-25
UA127350C2 (uk)	2023-07-26
AU2024219582A1 (en)	2024-10-03
EP3645063A4 (fr)	2021-04-14
US20230338614A1 (en)	2023-10-26
WO2019005848A1 (fr)	2019-01-03
ES3018883T3 (en)	2025-05-19
EP4169539C0 (fr)	2025-01-29
CN111263646A (zh)	2020-06-09
ES2935887T3 (es)	2023-03-13
JP2025020289A (ja)	2025-02-12
EP3645063A1 (fr)	2020-05-06
EP3645063B1 (fr)	2022-09-28
IL271692B2 (en)	2023-06-01
IL271692A (en)	2020-02-27
EP4169539A1 (fr)	2023-04-26
EP4169539B1 (fr)	2025-01-29

Publication	Publication Date	Title
MA49520A (fr)	2021-04-14	Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés d'utilisation
EP3493676A4 (fr)	2020-04-29	Compositions antimicrobiennes à base de polymère et leurs procédés d'utilisation
MA45280A (fr)	2019-01-09	Conjugués anticorps-médicament à base d'éribuline et leurs procédés d'utilisation
EP3775203A4 (fr)	2022-03-30	Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3684423A4 (fr)	2021-06-30	Virus adéno-associé à variant de capsides et leurs procédés d'utilisation
EP3634430A4 (fr)	2021-04-14	Agents multibiotiques et procédés d'utilisation de ceux-ci
EP3897564A4 (fr)	2022-10-19	Agents de comblement tissulaire à base de soie-acide hyaluronique et leurs procédés de préparation et d'utilisation
EP3717636A4 (fr)	2021-09-08	Variants de capsides de virus adéno-associé et leurs procédés d'utilisation
EP3630199A4 (fr)	2021-11-10	Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3630788A4 (fr)	2021-04-28	Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3630789A4 (fr)	2021-06-16	Compositions d'oligonucléotides et leurs procédés d'utilisation
EP3432933A4 (fr)	2019-12-04	Adhésifs biocompatibles et leurs procédés d'utilisation
EP3704239A4 (fr)	2021-08-18	Compositions de casz et procédés d'utilisation
EP3684364A4 (fr)	2021-06-02	Pyridazinones et leurs procédés d'utilisation
EP3416634A4 (fr)	2019-10-09	Agents immunomodulateurs et leurs procédés d'utilisation
EP3436061A4 (fr)	2019-12-04	Compositions de conjugués saccharide-polypeptide polymérisables et leurs procédés d'utilisation
EP3436048A4 (fr)	2019-11-27	Néoantigènes et leurs procédés d'utilisation
MA47499A (fr)	2019-12-25	Anticorps anti-tau et leurs procédés d'utilisation
EP3377042A4 (fr)	2019-05-29	Substances et procédés de traitement de myopathies à base de titine et d'autres titinopathies
EP3472200A4 (fr)	2020-04-01	Anticorps anti-myostatine et leurs procédés d'utilisation
EP3435956A4 (fr)	2020-01-15	Compositions photo-stabilisées et leurs procédés d'utilisation
EP3436476A4 (fr)	2020-04-29	Anticorps anti-ryk et leurs procédés d'utilisation
EP3635000A4 (fr)	2021-04-14	Manabodies et procédés d'utilisation
EP3731867A4 (fr)	2022-04-06	Anticorps anti-lrp5/6 et leurs procédés d'utilisation
EP3846808A4 (fr)	2022-08-17	Inhibiteurs de papd5 et leurs procédés d'utilisation